REGENXBIO, based in Rockville, MD, is a pioneering clinical-stage biotechnology company focused on advancing gene therapy to improve lives. Through their innovative NAV Technology Platform, they are developing one-time treatments for patients with common and rare diseases in the retinal, metabolic, and neurodegenerative therapeutic areas.
With a mission to deliver curative solutions, REGENXBIO is dedicated to making a difference for patients and their families. Their robust clinical programs and commitment to innovation position them at the forefront of gene therapy research and development.
Generated from the website